San Segundo Arribas, David

INMUNOPATOLOGÍA
Education:
2001 Fundamental Biology and Biotechnology, Santiago de Compostela University, A Coruña, Spain.
2007 Clinical Immunologist, Marqués de Valdecilla Hospital, Cantabria, Spain
2010 PhD Molecular Biology, Cantabria University, Cantabria, Spain.
Career Profile
David San Segundo is a Clinical Immunologist at Marqués de Valdecilla University Hospital from 2011 and honorific collaborator in Medicine School at Cantabria University from 2005. He achieved the Fundamental Biology and Biotechnology degree at Santiago de Compostela University in 2001. He perfomed the Clinical Immunology residence in the Immunology Department at Marqués de Valdecilla University Hospital, Santander, Spain. He was engaged to the consolidated research group in Autoimmunity and Transplantation at IDIVAL in 2005. Once the clinical immunologist degree was obtained in 2007, he received a Lopez-Albo grant from IDIVAL, which gave the oppotunity to spend two years in the Transplantation Research Immunology Group at John Radcliffe Hospital, Oxford University, UK in 2009. He obtained PhD from Cantabria University, Santander, SPAIN in 2010. From 2011 is the clinical immunologist in charge of Cellular Immunology and a staff member of Histocompatibility Laboratory in the Immunology Department at Marqués de Valdecilla Hospital, Santander, Spain. From 2013 is Coordinator of Flow Cytometry and Cell Sorting Core at IDIVAL, Santander, Spain.
His research is based in Transplant Immunology, and focussed in the regulatory mechanisms to allograft, mainly regulatory T cells and myeloid-derived suppressor cells.
Dr. San Segundo has published over 50 peer-reviewed articles and book chapters in Transplant immunology field, including articles with high-impact journals such as Transplantation, Frontiers in Immunology, PlosONE, Immunology, Clinical Immunology, Transplant Immunology, World Journal Gastroenterology and Liver Transplantation.
ORCID ID: 0000-0001-5745-9072
Anterior 1 2 3 4 5 6 7 8 9 10  ... Siguiente 
Proyectos